Wyndly (YC W21) is a health care startup founded in 2020 with the slogan "Life's better without allergies." The company aims to provide lifelong relief to people with allergies through personalized oral allergy drops that train the immune system to combat individual allergy triggers. Offering unlimited doctor access and entirely at-home care, Wyndly focuses on making allergy care convenient. In its latest funding round on 08 February 2023, the company successfully secured a $2.00M investment from prominent investors such as Goodwater Capital, Y Combinator, Civilization Ventures, Sweater, and Kevin Mahaffey. With its innovative approach to allergy treatment and prominent backing, Wyndly is poised for potential growth and impact in the health care industry.
No recent news or press coverage available for Wyndly (YC W21).